An immune and cancer cell-targeting antibody therapy has shown potential to eradicate residual traces of deadly blood cell cancer, multiple myeloma, according to interim results from a clinical trial.

Treatment with an immune and cancer cell-targeting antibody therapy eradicates residual traces of the blood cell cancer ...

An American health care company hopes to ship millions of coronavirus antibody tests across the country in hopes of helping both researchers in finding a treatment and public health officials in ...

HONOLULU (KITV4) -- A simple blood test can indicate the difference between someone who has recovered from COVID-19 and someone who continues to produce antibodies after getting vaccinated. Tests show ...

The FDA has issued emergency authorizations to 12 antibody tests for the virus. As federal officials gradually begin reopening the country, expanded testing is central to the conversation. Until now, ...

An antineutrophil cytoplasmic antibodies (ANCA) test is a blood test that checks for proteins your immune system makes to fight germs. This test can help your doctor diagnose autoimmune diseases like ...

A new MD Anderson antibody, 77A, restores treatment response in resistant myeloma, lymphoma and solid tumors, offering a ...

A type of COVID-19 test rushed out in the early days of the pandemic, before vaccines became widely available, isn’t much use any more for most people, doctors say. So-called antibody blood tests can ...

Most people with lupus have antinuclear antibodies (ANAs) in their blood. But a positive ANA test doesn’t always mean lupus. The test can be positive in people with other autoimmune illnesses — ...

Such a treatment also may help determine how many people were exposed. With a limited supply of COVID-19 tests in the United States, people with mild symptoms are less likely to be tested, leaving ...

Findings set the stage for further investigation of hSFRP2 mAb as a targeted therapy for triple-negative breast cancer.